Immunovant, Inc.IMVTNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-413.84M
↓ 145% below average
Average (7y)
$-168.93M
Historical baseline
Range
High:$-448.00
Low:$-413.84M
CAGR
+17.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-413.84M | -59.6% |
| 2024 | $-259.34M | -22.9% |
| 2023 | $-210.96M | -34.6% |
| 2022 | $-156.73M | -45.9% |
| 2021 | $-107.43M | -61.8% |
| 2020 | $-66.39M | -14818650.0% |
| 2019 | $-448.00 | +100.0% |
| 2018 | $-136.74M | - |